RxPrep Posts - TopicsExpress

New Drug Update: Edoxaban (Savayasa®) Last week FDA approved a
New Drug Update: Edoxaban (Savayasa®) Last week FDA approved a new oral factor Xa inhibitor for treatment of DVT and PE following 5-10 days of initi...

Drug Therapy Question for The Week - Please Answer All Parts
Drug Therapy Question for The Week - Please Answer All Parts Completely. $10 Coffee Card for first complete and correct response. Good luck! (1) ...

Today’s Drug Therapy Question is on Compounding Terminology. $10
Today’s Drug Therapy Question is on Compounding Terminology. $10 Starbucks card for the 1st complete, correct response. Our Warning Label: If any re...

New Drug Approval: Oritavancin (Orbactiv) approved for acute
New Drug Approval: Oritavancin (Orbactiv) approved for acute bacterial skin and skin structure infections (ABSSSI)– approved dose is 1200 mg IV as ...

Drug Therapy Question Time! This week, we will focus on the
Drug Therapy Question Time! This week, we will focus on the appropriate use of antiplatelet agents. Please provide 2 contraindications/significant w...